TWF1 and cancer: High expression of TWF1 was associated with poor prognosis of OS (Overall survival) for cancers including CESC (P=0.045), LUAD (P=0.00014), MESO (Mesothelioma) (P=0.0016) and PAAD (Pancreatic adenocarcinoma) (P=0.031) (Figure 3A).